Takeda Pharmaceuticals (4502.T) and Astex Pharmaceuticals are coming together to share proprietary data for training an artificial intelligence model to assist drug discovery and development.
The companies are joining a consortium that includes AbbVie (ABBV.N)
and Johnson & Johnson <JNJ.N>, and will contribute data from several thousand experimentally determined protein–small molecule structures to train an AI model called OpenFold3, life sciences company Apheris said on Wednesday.
Read more | REUTERS